Top Healthcare Equipment Companies To Watch In Right Now

Sunset for the A-10 Thunderbolt II? Or a new dawn? Photo: U.S. Air Force.

The U.S. Air Force wants to kill the A-10 Thunderbolt II. Really, really,�really�wants to kill it.

But the Air Force's paymaster does not. And when all's said and done, that's what the debate over the fate of America's best tank-destroying warplane may come down to -- whether the folks who control the Air Force's purse strings want to keep the A-10 flying.

A few weeks ago, we went over a few trial balloons that the Air Force has floated, in case Congress won't let it retire its fleet of 326 A-10 "Warthogs." To save the estimated $700 million a year it costs to keep the A-10s fueled, maintained, and flying, USAF has suggested it could retire its entire fleet of 66 B-1B long-range bombers instead -- or put about a third of its 1,018 F-16 fighter jets into mothballs.

That makes sense because, as Georgia Senators Saxby Chambliss and Johnny Isakson have pointed out, the A-10 is cheaper to fly, per flying hour, than either the F-16 or the B-1. This suggests that cutting the more expensive planes from the Air Force's arsenal, and sticking with the older -- but cheaper and more effective -- A-10 is the right move to make.

5 Best Healthcare Equipment Stocks To Own Right Now: Braskem SA (BRKM5)

Braskem SA is a Brazil-based company primarily engaged in the manufacture of basic petrochemical products. The Company operates in five segments: Basic petrochemicals, Polyolefins, Vinyls, International businesses and Chemical Distribution. The Company�� products portfolio includes ethylene, propylene, butadiene, toluene, xylene, benzene, gasoline, diesel oil, liquefied petroleum gas (LPG), as well as thermoplastic resins, such as polyethylene (PE), polypropylene (PP) and polyvinyl chloride (PVC). Additionally, Braskem is also engaged in the import and export of chemicals, petrochemicals and fuels; the production, supply and sale of utilities, such as steam, water, compressed air, industrial gases, as well as the provision of industrial services, and the production, supply and sale of electric energy for its own use and use by other companies. The Company also invests in other companies, either as a partner or shareholder. Advisors' Opinion:

• [By Harry Suhartono]

  Brazil�� Ibovespa rose for a third day as traders pared bets on higher borrowing costs in Brazil, boosting the outlook for companies that sell in the local market. B2W Cia. Digital led gains among retailers, with Lojas Americanas SA (LAME3) and Natura Cosmeticos SA (NATU3) also trading higher. Petrochemicals producer Braskem SA (BRKM5) was the worst performer on the equity gauge after O Estado de S.Paulo reported Petroleo Brasileiro SA (PETR4) is seeking to raise prices of naphtha sold to the company by 5 percent.

Top Healthcare Equipment Companies To Watch In Right Now: Prothena Corporation PLC (PRTA)

Prothena Corporation PLC, incorporated on September 26, 2012, is an Ireland-based, clinical-stage biotechnology company. The Company is engaged in discovering and developing monoclonal antibodies that are directed towards misfolded proteins or improper cell adhesion. Its pipeline includes NEOD001, PRX002 and PRX003. The Company�� work in protein misfolding could result in therapies to treat several neurodegenerative diseases, including AL (primary) and AA (secondary) forms of amyloidosis (NEOD001), Parkinson's disease and related synucleinopathies (PRX002). Its cell adhesion development activities could generate new therapies to treat inflammatory diseases and metastatic cancers (PRX003). The Company�� program, NEOD001, is in Phase 1. In addition to antibodies directed to neo-epitope targets, it is developing antibodies directed to other targets. The Company has generated antibodies against cell adhesion targets expressed on certain pathogenic Th17 immune cells and tumor cells.

The Company�� pipeline also includes several late discovery stage programs for which it is testing antibodies in preclinical models of disease. It is also generating additional antibodies against other targets involved in protein misfolding and cell adhesion for characterization in vivo and in vitro.

NEOD001 for Amyloidosis

NEOD001 is a monoclonal antibody that targets the amyloid that accumulates in both AL and AA forms of amyloidosis. The antibody was designed to not react with normal serum amyloid A and only with the aberrant cleaved form of the protein (amyloid A).

PRX002 for Parkinson�� Disease

The Company has generated antibodies targeting alpha-synuclein that may slow or reduce the neurodegeneration associated with synuclein misfolding and/or transmission. It has tested these antibodies in various cellular and animal models of synuclein-related disease. In a transgenic mouse model of Parkinson�� disease, passive immunization with 9E4, a murine ver! sion of PRX002, reduced the appearance of synuclein pathology, protected synapses and improved performance by the mice in behavioral testing. The humanized antibody product candidate PRX002 has advanced into manufacturing and preclinical testing.

PRX003 for Inflammatory Diseases and Cancers

The Company is developing PRX003, a monoclonal antibody targeting MCAM for the potential treatment of inflammatory diseases and cancers. It has generated monoclonal antibodies that block MCAM-mediated cell adhesion and have been shown to delay relapse and severity of relapse in a mouse model of multiple sclerosis known as experimental autoimmune encephalomyelitis. The Company�� antibodies are being tested in animal models of inflammatory diseases and cancers. Based on early results from these studies, it has identified a clinical candidate, PRX003. It has advanced this antibody into manufacturing and intends to advance this antibody into preclinical testing.

Advisors' Opinion:

• [By MONEYMORNING]

  For its part, CSD also is tapping into the biotech boom. The second firm that it holds and we like is Prothena Corporation PLC (Nasdaq: PRTA), a clinical-stage biotechnology firm focused on Parkinson's disease and other neurodegenerative disorders.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Prothena Corporation plc (NASDAQ: PRTA) shares shot up 21.60 percent to $45.19 after the company reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00.

• [By Lauren Pollock]

  Roche Holding AG(ROG.VX) has entered a pact with Prothena Corp.(PRTA) PLC to develop and commercialize a treatment the clinical-stage biotechnology firm is developing for Parkinson’s disease. In after-hours trading, Prothena’s stock rose 8.6% to $29.75 premarket.

• [By Jake L'Ecuyer]

  Shares of Prothena Corporation plc (NASDAQ: PRTA) got a boost, shooting up 6.99 percent to $32.00 after the company reported the successful start of a Phase 1 clinical trial of PRX002 for the treatment of Parkinson's disease. Citigroup initiated coverage on the stock with a Buy rating and a $50.00 price target.

Top Healthcare Equipment Companies To Watch In Right Now: Wind Works Power Corp (WWPW)

Wind Works Power Corp. (Wind Works), incorporated on November 20, 2002, the Company intends to develop wind parks. The Company will assemble land packages, secure requisite environmental permitting, provide wind testing by erecting towers to measure wind speed. The Company operates 4.6 megawatts in Germany, in which it has a 49% ownership stake.

The Company�� projects include Ganaraska Wind Park, Settlers Landing, Skyway 126, Ganaraska and Thunder Spirit. The Company focuses to develop 77 megawatts of near-term permitted projects in Germany; 50 megawatts of FIT contracted projects in Ontario; and 320 megawatts of projects in the United States.

Advisors' Opinion:

• [By Peter Graham]

  Small cap green stocks Geo Finance Corporation (OTCMKTS: GEFI), Dragon Polymers Inc (OTCMKTS: DRAG) and Wind Works Power Corp (OTCMKTS: WWPW) have been getting some extra attention lately from various investment newsletters or investor alerts. However, two of these small cap green stocks have also been the subject of paid promotions or investor relations types of activities. So will these green small cap stocks produce some greenbacks for investors and traders alike? Here is a closer look and a reality check:

Top Healthcare Equipment Companies To Watch In Right Now: USell.com Inc (USEL)

usell.com, Inc. (uSel), formerly known as Upstream Worldwide, Inc., incorporated on November 18, 2003, is a technology-based company. The Company focuses on creating an online marketplace where individuals interested in selling small consumer electronics.

The Company through its wholly owned subsidiaries helps individuals monetize household items. Household items, such as small consumer electronics that they no longer using.

The Company competes with eBay.com, craigslist.com and BestBuy, Inc.

Advisors' Opinion:

• [By EquityOptionsGuru]

  Over the past decade, online marketplaces have been springing up at a rapid fire pace.� Consumers continue to seek new outlets to both buy and sell products at reasonable prices with high efficiency.� This need can be seen in the re-commerce industry, which represents an annual market of $57 billion.� Although eBay (NASDAQ: EBAY) has been the dominant player for the better part of a decade, it is facing increasing pressure from other marketplaces for cost and convenience reasons.� One such marketplace, uSell.com (OTC PINK: USEL), appears poised to rival eBay for years to come.

Top Healthcare Equipment Companies To Watch In Right Now: MutualFirst Financial Inc.(MFSF)

MutualFirst Financial, Inc. operates as a holding company for MutualBank that provides financial products services to individuals and businesses. It accepts various savings deposit accounts, NOW and demand accounts, and certificates of deposit. The company also provides one- to four-family residential mortgage loans, multi-family and commercial real estate loans, construction and development loans, commercial business loans, and consumer loans, including home equity and lines of credit, home improvement, auto, boat, and recreational vehicle loans, as well as loans secured by savings deposits, and credit card and unsecured loans. In addition, it operates as an insurance agent and sells life insurance, and credit-life and health insurance products. Further, the company provides investment money management and trust services. It operates 33 full service financial centers located in Delaware, Elkhart, Grant, Kosciusko, Randolph, St. Joseph, and Wabash counties, Indiana. The co mpany was founded in 1889 and is headquartered in Muncie, Indiana.

Advisors' Opinion:

• [By Tim Melvin]

  MutualFirst Financial (MFSF) makes the list, trading at 80% of book value and yielding 1.61%. The bank has total assets of about $1.4 billion and is located in Muncie, Ind. Like a lot of small banks today, the story here is one of steady credit improvement and compressed net interest margins. It is one of many smaller institutions that I think will eventually be taken over; the current regulatory climate simply does not favor little banks. Insiders own about 10% of the stock, so they are invested in the idea of a much higher stock price.

• [By Tim Melvin]

  PL Capital has not filed any 13Ds in a couple of months, but earlier this year it disclosed a 5.99% position in shares of First Advantage Bancorp (FABK). The Clarksville, Tenn.-based bank has seven branches and trades at about 75% of book value. PL Capital also filed a 13D announcing 8% ownership of Mutual First Financial (MFSF) over the summer. The bank has 31 branches and is based in Muncie, Ind. — an area that has seen substantial consolidation in the past few years.